Johnson & Johnson hiked U.S. prices on roughly two dozen prescription medications on Thursday, including psoriasis treatment Stelara, prostate cancer drug Zytiga, and blood thinner Xarelto, Reuters reports. The company joined many other peers that boosted U.S. prices on hundreds of prescription drugs earlier this month, the report says. Most of the J&J price hikes were between 6%-7%, the report says, citing data from Rx Savings Solutions. The increases came as Congressional Democrats introduced a bill aimed at cutting the cost of prescription medicines for American consumers, the report says
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.